| Characterization of ΔNp73 expression and regulation in gastric and esophageal tumors. | |
| | |
MedLine Citation:
|
PMID: 20676143 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
p73 is a member of the p53 protein family. Although the tumor suppressor function of p53 is clearly defined, the role of p73 in tumorigenesis is still a matter of debate. A complex pattern of expression of p73 isoforms makes it difficult to unambiguously interpret the experimental results. Previously, we along with others have found that the N-terminally truncated isoform of p73, ΔNp73, has potent anti-apoptotic and oncogenic properties in vitro and in vivo. In this study, we analyzed, for the first time, the regulation of ΔNp73 in a large number of gastric, gastroesophageal junction and esophageal tumors. We found that expression of ΔNp73 mRNA and protein is increased in these neoplasms. Furthermore, the upregulation of the ΔNp73 protein is significantly associated with poor patient survival. Oncogenic properties of ΔNp73 were further confirmed by finding that ΔNp73 facilitates anchorage-independent growth of gastric epithelial cells in soft agar. As little is currently known about the regulation of ΔNp73 transcription, we investigated the alternative p73 gene promoter that mediates the ΔNp73 expression. Analyzing the ΔNp73 promoter in silico as well as by using chromatin immunoprecipitation, site-directed mutagenesis and deletion analyses, we identified the evolutionary conserved region within the ΔNp73 promoter that contains binding sites for HIC1 (hypermethylated in cancer) protein. We found that HIC1 negatively regulates ΔNp73 transcription in mucosal epithelial cells. This leads to a decrease in ΔNp73 protein levels and may normally control the oncogenic potential of the ΔNp73 isoform. |
| | |
Authors:
|
A E Vilgelm; S-M Hong; M K Washington; J Wei; H Chen; W El-Rifai; A Zaika |
Related Documents
:
|
9307713 - P53 mutations and protein expression in primary cultures of normal oral mucosa in smoke... 18690233 - P53 mrna controls p53 activity by managing mdm2 functions. 18715233 - Oncogenic braf(v600e) inhibits bim expression to promote melanoma cell survival. |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural Date: 2010-08-02 |
Journal Detail:
|
Title: Oncogene Volume: 29 ISSN: 1476-5594 ISO Abbreviation: Oncogene Publication Date: 2010 Oct |
Date Detail:
|
Created Date: 2010-10-28 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8711562 Medline TA: Oncogene Country: England |
Other Details:
|
Languages: eng Pagination: 5861-8 Citation Subset: IM |
Affiliation:
|
Department of Surgery, Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center, Nashville, TN 37232, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
| Grant Support | |
ID/Acronym/Agency:
|
CA108956/CA/NCI NIH HHS; UL1RR024975/RR/NCRR NIH HHS |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: p66(Shc) restrains Ras hyperactivation and suppresses metastatic behavior.
Next Document: Cell cycle-dependent acetylation of Rb2/p130 in NIH3T3 cells.